Diversified Consumer Services
Company Overview of University of Cambridge
University of Cambridge is an educational institution that offers graduate, postgraduate, and research programs in the field of science, business, social sciences, and law. It offers courses in history, environmental studies, psychology, sociology, zoology, oriental studies, business administration, philosophy, biochemistry, music, engineering, geology, architecture, international relations, and medicine. The institution was founded in 1209 and is based in Cambridge, United Kingdom.
The Old Schools
Cambridge, CB2 1TN
Founded in 1209
Key Executives for University of Cambridge
Regius Professor of Physic
Master of Pembroke College
Head of Institute for Stem Cell Biology
Compensation as of Fiscal Year 2014.
University of Cambridge Key Developments
MedImmune Announces Partnership with the University of Cambridge
Oct 16 14
AstraZeneca, together with its global biologics research and development arm, MedImmune, announced that it has entered into four new collaborations with the University of Cambridge, building further on their existing partnership. The latest collaborations reinforce AstraZeneca's commitment to creating a permeable research infrastructure in Cambridge following the company's decision to locate one of its three global research and development centres and its global headquarters in the city that has been home to MedImmune's biologics research laboratories for 25 years. The agreements build on the existing strategic partnership between AstraZeneca, MedImmune and the University of Cambridge, which includes a substantial oncology research programme and co-location of AstraZeneca scientists at the Cancer Research UK Cambridge Institute, the large single facility conducting cancer research in the University of Cambridge.
University of Cambridge Presents at 4th Annual Biobanking, Jun-24-2014 11:00 AM
Mar 19 14
University of Cambridge Presents at 4th Annual Biobanking, Jun-24-2014 11:00 AM. Venue: Holiday Inn Regents Park, Carburton Street, Londong, United Kingdom. Speakers: Matt Sims, Head of Research Operations, MRC Epidemiology.
MedImmune Signs Three-Year Oncology Research Collaboration with University of Cambridge
Mar 14 14
AstraZeneca's global biologics R&D unit, has signed a three-year oncology research collaboration with the University of Cambridge. It was reported that the collaboration is aimed at advancing cancer research by using imaging technologies to measure key biologic changes within growing tumours. MedImmune will contribute both funding and a post-doctoral scientist to work within the laboratory of professor Kevin Brindle at the University of Cambridge in the area of tumour targeted therapies. The company stated that tumour targeted therapies includes antibodies that are armed to kill tumour cells, including antibody-drug conjugates that selectively aim powerful drugs at cancer cells.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|